Bloodstream Infection, Venous Thrombosis, and Peripherally Inserted Central Catheters: Reappraising the Evidence

被引:189
作者
Chopra, Vineet [1 ]
Anand, Sarah [1 ]
Krein, Sarah L. [1 ,2 ]
Chenoweth, Carol [3 ]
Saint, Sanjay [1 ,2 ]
机构
[1] Univ Michigan Hlth Syst, Div Gen Internal Med, Ann Arbor, MI USA
[2] Univ Michigan Hlth Syst, Ann Arbor Vet Affairs Med Ctr, Hosp Outcomes Program Excellence, Ann Arbor, MI USA
[3] Univ Michigan Hlth Syst, Div Infect Dis, Ann Arbor, MI USA
关键词
Central line-associated bloodstream infections; Peripherally inserted central catheters; Venous thrombosis; INTENSIVE-CARE-UNIT; RISK-FACTORS; HEMATOLOGICAL MALIGNANCIES; RETROSPECTIVE ANALYSIS; INTRAVENOUS THERAPY; CANCER-PATIENTS; ACCESS DEVICES; COMPLICATIONS; THROMBOEMBOLISM; PREVENTION;
D O I
10.1016/j.amjmed.2012.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The widespread use of peripherally inserted central catheters (PICCs) has transformed the care of medical and surgical patients. Whereas intravenous antibiotics, parenteral nutrition, and administration of chemotherapy once necessitated prolonged hospitalization, PICCs have eliminated the need for such practice. However, PICCs may not be as innocuous as once thought; a growing body of evidence suggests that these devices also have important risks. This review discusses the origin of PICCs and highlights reasons behind their rapid adoption in medical practice. We evaluate the evidence behind 2 important PICC-related complications-venous thrombosis and bloodstream infections-and describe how initial studies may have led to a false sense of security with respect to these outcomes. In this context, we introduce a conceptual model to understand the risk of PICC-related complications and guide the use of these devices. Through this model, we outline recommendations that clinicians may use to prevent PICC-related adverse events. We conclude by highlighting important knowledge gaps and identifying avenues for future research in this area. (C) 2012 Elsevier Inc. All rights reserved. The American Journal of Medicine (2012) 125, 733-741
引用
收藏
页码:733 / 741
页数:9
相关论文
共 71 条
[1]  
Akers Adam S, 2009, J Hosp Med, V4, pE1, DOI 10.1002/jhm.446
[2]   Thromboprophylaxis for patients with cancer and central venous catheters [J].
Akl, Elie A. ;
Kamath, Ganesh ;
Yosuico, Victor ;
Kim, Seo Young ;
Barba, Maddalena ;
Sperati, Francesca ;
Cook, Deborah J. ;
Schunemann, Holger J. .
CANCER, 2008, 112 (11) :2483-2492
[3]   Peripherally inserted central venous catheters in the acute care setting: A safe alternative to high-risk short-term central venous catheters [J].
Al Raiy, Basel ;
Fakih, Mohamad G. ;
Bryan-Nomides, Nicole ;
Hopfner, Debi ;
Riegel, Elizabeth ;
Nenninger, Trudy ;
Rey, Janice ;
Szpunar, Susan ;
Kale, Pramodine ;
Khatib, Riad .
AMERICAN JOURNAL OF INFECTION CONTROL, 2010, 38 (02) :149-153
[4]   Moving toward Elimination of Healthcare-Associated Infections: A Call to Action [J].
不详 .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (11) :1101-1105
[5]  
Aw A, 2012, THROMB RES
[6]   Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin [J].
Bashir, Muhammad H. ;
Olson, Linda K. M. ;
Walters, Shelley-Ann .
AMERICAN JOURNAL OF INFECTION CONTROL, 2012, 40 (04) :344-348
[7]  
Baxi S SE, 2008, 48 ANN INT SCI C ANT
[8]   Guidelines on the insertion and management of central venous access devices in adults [J].
Bishop, L. ;
Dougherty, L. ;
Bodenham, A. ;
Mansi, J. ;
Crowe, P. ;
Kibbler, C. ;
Shannon, M. ;
Treleaven, J. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 (04) :261-278
[9]   Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies [J].
Boersma, R. S. ;
Jie, K. -S. G. ;
Verbon, A. ;
van Pampus, E. C. M. ;
Schouten, H. C. .
ANNALS OF ONCOLOGY, 2008, 19 (03) :433-442
[10]  
BOTTINO J, 1979, CANCER-AM CANCER SOC, V43, P1937, DOI 10.1002/1097-0142(197905)43:5<1937::AID-CNCR2820430554>3.0.CO